Johnson & Johnson announced publication of the primary results from the MEMBRANE randomized controlled trial in JAMA Neurology. The study showed that adding middle meningeal artery embolization (MMAe)… read more.
Novocure announced topline results from its Phase 3 TRIDENT trial, which evaluated the initiation of Tumor Treating Fields (TTFields) therapy for newly diagnosed glioblastoma (GBM) at the start… read more.
A self-directed approach to cognitive behavioral therapy for chronic pain (CBT-CP) produces comparable — and in some respects better — outcomes than clinician-delivered CBT-CP, according to a new… read more.
A new study from Northwestern University and Ann & Robert H. Lurie Children’s Hospital of Chicago highlights the critical role paid paternal leave plays in supporting new dads’… read more.
DNA testing kits are often gifted for Father’s Day, Christmas and special occasions. The idea of learning more about yourself and unearthing some long-forgotten family history is certainly… read more.
Patients are less likely to become long-term benzodiazepine users when they are initially prescribed shorter courses, a single medication, or short-acting agents, according to a large new study… read more.
Lundbeck A/S today announced that new migraine clinical data will be presented at the European Academy of Neurology (EAN) Congress 2026, taking place 27–30 June in Geneva, Switzerland…. read more.
Cognitive behavioural therapies for insomnia (CBT-I) are increasingly being delivered online in order to improve accessibility. However, although insomnia and anxiety frequently occur together in older adults, few… read more.
Sunscreen is overwhelmingly promoted in popular TikTok videos, but content containing health misinformation about sunscreen attracts disproportionately high audience engagement, according to a new study published June 18th in… read more.
Researchers at Mass General Brigham have demonstrated that older U.S. veterans who initiated statin therapy were significantly less likely to develop frailty over time, suggesting that the cholesterol-lowering… read more.
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced 11 late-breaking presentations at SLEEP 2026, including notable new research showcasing the comprehensive treatment outcomes of Xywav® (calcium, magnesium, potassium, and sodium… read more.
Shingles vaccination reduces dementia risk, researchers reported on June 15, 2026 in the Annals of Internal Medicine. “Receipt of RZV [recombinant shingles vaccine] during admission to a skilled-nursing… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
